New AI blood test tracks pancreatic cancer treatment response

'Fast-fail' AI blood test could steer patients with pancreatic cancer away from ineffective therapies

An artificial intelligence technique for detecting DNA fragments shed by tumors and circulating in a patient's blood could help clinicians more quickly identify and determine if pancreatic cancer therapies are working.

Pancreatic Cancer Conference at Quirónsalud

Quirónsalud Torrevieja Hospital hosted over 100 medical experts from across the Valencian Community to explore the latest advances in the treatment of pancreatic cancer. Last Thursday, Quirónsalud Torrevieja Hospital held the scientific event titled “Update on the Management and Treatment of Pancreatic Cancer”, attended by more than one hundred healthcare professionals from various locations… Source

New AI blood test tracks pancreatic cancer treatment response

An artificial intelligence technique for detecting DNA fragments shed by tumors and circulating in a patient's blood, developed by Johns Hopkins Kimmel Cancer Center investigators, could help clinicians more quickly identify and determine if pancreatic cancer therapies are working.

Geneseeq’s new blood test may detect pancreatic cancer early

Geneseeq Technology is developing a blood test that uses cell-free DNA (cfDNA) and artificial intelligence (AI) to detect early-stage pancreatic ductal adenocarcinoma — the most common type of pancreatic cancer, which forms in the cells of the pancreas responsible for producing digestive juices — that is often missed by standard screening tests. In a new study, an AI-based machine learning model looked for patterns in cfDNA — DNA fragments relea…

Pancreatic cancer: clinical deployment of AI system for early detection

Survival rates for pancreatic cancer rise drastically the earlier it is detected, but early-stage tumors are notoriously difficult to spot. A new AI-powered diagnostic system is set to improve this.